| First Author | Li J | Year | 2013 |
| Journal | Carcinogenesis | Volume | 34 |
| Issue | 9 | Pages | 2099-108 |
| PubMed ID | 23695722 | Mgi Jnum | J:200523 |
| Mgi Id | MGI:5508817 | Doi | 10.1093/carcin/bgt172 |
| Citation | Li J, et al. (2013) Myeloid TGF-beta signaling contributes to colitis-associated tumorigenesis in mice. Carcinogenesis 34(9):2099-108 |
| abstractText | Myeloid cells have a critical role in maintaining intestinal homeostasis and regulating the development of inflammatory bowel disease and colitis-associated cancer (CAC). However, the signaling pathways that control the function of colonic myeloid cells in these pathological processes are still poorly defined. In this study, we demonstrate that transforming growth factor-beta (TGF-beta) signaling in colonic myeloid cells is significantly involved in the development of CAC. Myeloid TGF-beta receptor II (Tgfbr2)-deficient mice showed reduced susceptibility to chemically induced colitis-associated tumorigenesis, as evidenced by decreases in number and size of tumors. Myeloid Tgfbr2 deficiency markedly decreased the production of interleukin-6 and tumor necrosis factor-alpha, two proinflammatory cytokines that are essential for colonic tumorigenesis; in addition, a marked increase in the proportions of Foxp3(+)CD4(+) regulatory T cells was observed in the colonic lamina propria in the initial stage of CAC. Loss of myeloid Tgfbr2 was associated with a decrease in the presence of F4/80 positive macrophages and a downregulation of phosphorylated STAT3, proliferative cell nuclear antigen and cyclin D1 expression in colonic adenoma tissues. TGF-beta enhanced macrophage recruitment, at least in part, through modulating the expression of the chemokine (C-C motif) receptor 2 (CCR2) ligands in tumor environment and the CCR2 signaling in macrophages. Collectively, these results suggest that myeloid TGF-beta signaling modulates intestinal inflammation and significantly promotes tumorigenesis in the development of colitis-associated colon cancer. |
